Antineutrophil Cytoplasmic Antibodies associated vasculitis in Patients with Tuberculosis

Main Article Content

Chutipan SaeJung
Parichat Uea-areewongsa

Abstract

A sixty-five-year-old female was diagnosed disseminated tuberculosis (TB) infection. Two weeks after initiating TB treatment, she developed rapid progressive glomerulonephritis, polyneuropathy, active alveolitis, peripheral ulcerative keratitis (PUK), and episcleritis. Positivity of a high level of anti-Myeloperoxidase (MPO) Antibody, which is compatible with antineutrophil cytoplasmic antibodies-associated vasculitis. After receiving monthly intravenous immunoglobulin (IVIG) treatment and concurrent steroid therapy alongside anti-tuberculosis drugs, her clinical condition improved.

Article Details

How to Cite
1.
SaeJung C, Uea-areewongsa P. Antineutrophil Cytoplasmic Antibodies associated vasculitis in Patients with Tuberculosis. Thai J Rheu [Internet]. 2024 Aug. 8 [cited 2024 Nov. 6];1(2):16-21. Available from: https://he04.tci-thaijo.org/index.php/tjr/article/view/1453
Section
Case Report

References

Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 2005;1(1):e5.

Hershkovitz I, Donoghue HD, Minnikin DE, Besra GS, Lee OY, Gernaey AM, et al. Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PLoS One. 2008;3(10):e3426.

Pradhan VD, Badakere SS, Ghosh K, Pawar AR. Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis. Indian J Med Sci. 2004;58(7):283-8.

Martínez-Martínez MU, Gómez-Gómez A, Oros-Ovalle C, Abud-Mendoza C. A male patient with cavitary pulmonary disease. Reumatol Clin. 2013;9(1):62-4.

Schmitt WH, van der Woude FJ. Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol. 2004;16(1):9-17.

Bossuyt X, Cohen Tervaert J-W, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, et al. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nature Reviews Rheumatology. 2017;13(11):683-92.

Sherkat R, Mostafavizadeh K, Zeydabadi L, Shoaei P, Rostami S. Antineutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis. Iran J Immunol. 2011;8(1):52-7.

Carvalho M, Dominoni RL, Senchechen D, Fernandes AF, Burigo IP, Doubrawa E. Cutaneous leukocytoclastic vasculitis accompanied by pulmonary tuberculosis. J Bras Pneumol. 2008;34(9):745-8.

Esquivel-Valerio JA, Flores-Suárez LF, Rodríguez-Amado J, Garza-Elizondo MA, Rendón A, Salinas-Carmona MC. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation. Clin Exp Rheumatol. 2010;28(1 Suppl 57):35-9.

Kakoullis L, Parperis K, Papachristodoulou E, Panos G. Infection-induced myeloperoxidase specific antineutrophil cytoplasmic antibody (MPO-ANCA) associated vasculitis: a systematic review. Clinical Immunology. 2020;220:108595.

Teixeira L, Mahr A, Jaureguy F, Noël LH, Nunes H, Lefort A, et al. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis. Rheumatology (Oxford). 2005;44(2):247-50.

Tan CD, Smith A, Rodriguez ER. Systemic necrotizing vasculitis induced by isoniazid. Cardiovascular Pathology. 2014;23(3):181-2.

Ji G, Zeng X, Sandford AJ, He JQ. Rifampicin-induced antineutrophil cytoplasmic antibody-positive vasculitis: a case report and review of the literature. Int J Clin Pharmacol Ther. 2016;54(10):804-7.

Ogata H, Kubo M, Tamaki K, Hirakata H, Okuda S, Fujishima M. Crescentic Glomerulonephritis due to Rifampin Treatment in a Patient with Pulmonary Atypical Mycobacteriosis. Nephron. 1998;78(3):319-22.